Regeneron Pharmaceuticals, Inc.

Advisors Asset Management, Inc. REGN

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/13/2026

Shares

2,379

Value ($000)

1,483

Weight

0.0%

2013 Q4 - 2026 Q2 (35 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/13/2026	1,483	0.0%	2,379	6/30/2026
2026 Q1	5/15/2026	2,384	0.0%	3,085	3/31/2026
2025 Q4	8/21/2026	2,524	0.0%	3,270	12/31/2025
2025 Q3	8/26/2026	1,926	0.0%	3,426	9/30/2025
2025 Q2	8/24/2026	2,356	0.0%	4,488	6/30/2025
2025 Q1	8/26/2026	3,405	0.1%	5,369	3/31/2025
2024 Q4	8/21/2026	3,679	0.1%	5,165	12/31/2024
2024 Q3	8/21/2026	5,895	0.1%	5,608	9/30/2024
2024 Q2	8/21/2026	6,971	0.1%	6,633	6/30/2024
2024 Q1	8/26/2026	7,331	0.1%	7,617	3/31/2024
2023 Q4	8/26/2026	7,355	0.2%	8,374	12/31/2023
2023 Q3	8/26/2026	7,732	0.2%	9,395	9/30/2023
2023 Q2	8/26/2026	6,477	0.1%	9,014	6/30/2023
2023 Q1	8/26/2026	7,960	0.2%	9,688	3/31/2023
2022 Q4	8/27/2026	6,022	0.1%	8,346	12/31/2022
2022 Q3	8/26/2026	5,434	0.1%	7,888	9/30/2022
2022 Q2	8/27/2026	4,748	0.1%	8,032	6/30/2022
2021 Q4	8/27/2026	6,828	0.1%	10,812	12/31/2021
2021 Q3	8/27/2026	8,142	0.1%	13,454	9/30/2021
2021 Q2	8/26/2026	7,878	0.1%	14,104	6/30/2021
2021 Q1	8/26/2026	8,040	0.1%	16,993	3/31/2021
2020 Q4	8/26/2026	10,493	0.2%	21,719	12/31/2020
2020 Q3	8/26/2026	12,458	0.2%	22,256	9/30/2020
2020 Q2	8/27/2026	14,574	0.3%	23,369	6/30/2020
2020 Q1	8/21/2026	10,628	0.3%	21,765	3/31/2020
2019 Q4	8/25/2026	7,805	0.1%	20,787	12/31/2019
2019 Q3	8/18/2026	4,852	0.1%	17,490	9/30/2019
2019 Q2	8/18/2026	4,249	0.1%	13,575	6/30/2019
2019 Q1	8/18/2026	3,994	0.1%	9,727	3/31/2019
2018 Q4	8/13/2026	2,708	0.1%	7,249	12/31/2018
2018 Q3	8/13/2026	1,564	0.0%	3,871	9/30/2018
2018 Q2	8/13/2026	1,713	0.0%	4,966	6/30/2018
2018 Q1	8/13/2026	2,231	0.0%	6,961	3/31/2018
2014 Q1	5/15/2014	2,745	0.0%	9,143	3/31/2014
2013 Q4	2/3/2014	2,308	0.0%	8,385	12/31/2013